Genpharmasec share news, announcements and annual reports
BSE: 531592Commercial Services & SuppliesSmall Cap
GENPHARMASEC LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1996
Last close ₹0.99₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.99.
30 Oct: open ₹0.97, high ₹1.00, low ₹0.97
52-week range of traded prices to 30 Oct 2026
₹0.75Low, 30 Mar 2026₹1.79High, 30 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹55 Cr3,222nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.83
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −1.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.50
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,79,151
Genpharmasec share news and announcements
611 announcements, routine notices left out, newest first. Page 13 of 13.
Jul 2012
Apr 2012
18 Apr · Results
Company has opted for submitting audited financial results for the year ended March 31, 2012 within 60 days from the end of financial year. ....
Feb 2012
7 Feb · Board Meeting on Feb 10, 2012
Meeting of the Board of Directors of the Company will be held on February 10, 2012, inter alia, to consider and discuss the following items: - ....
Jan 2012
25 Jan · Results
6 Jan · Results
Nov 2011
18 Nov · Change of Registered Office and Contact Number
Board of Directors of the Company at its meeting held on November 18, 2011, inter alia, have approved the shifting of registered office of the ....
Oct 2011
12 Oct · Results
Aug 2011
26 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 19, 2011 to September 23, 2011 (both days inclusive) ....
May 2011
24 May · Results
Feb 2011
21 Feb · Results
21 Feb · Results